Global Peptide Therapeutics Market Study 2016-2026, by Segment (Injection, Oral, … …), by Market (Cancer, Metabolic Disorders, … …), by Company (Sanofi, Teva, … …)
SKU ID :99ST-14636485 | Published Date: 25-Oct-2019 | No. of pages: 62Description
Summary
The global Peptide Therapeutics market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Injection
Oral
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Cancer
Metabolic Disorders
Central Nervous System
Others
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Peptide Therapeutics market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Injection
Oral
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Cancer
Metabolic Disorders
Central Nervous System
Others
Company Coverage (Sales data, Main Products & Services etc.):
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now